Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model.


PURPOSE Multiple myeloma (MM) is a progressive, malignant neoplasia with a worldwide, age-standardized annual incidence of 1.5 per 100 000 individuals and 5-year prevalence around 230 000 patients. Main favorable prognostic factors are younger age, low/standard cytogenetic risk, and undergoing stem cell transplantation. Our aim was to estimate the size of… (More)
DOI: 10.1002/pds.3927


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics